Pierre-Olivier GIRODET

août 2024 American Journal of Respiratory and Critical Care Medicine

Strategies for Identifying Biomarkers in Severe Asthma

Auteurs : Pierre-Olivier Girodet

juin 2022 Fundamental & Clinical Pharmacology

Clinical pharmacology: Current innovations and future challenges

Auteurs : Jean‐Luc Cracowski, Jean‐Sébastien Hulot, Silvy Laporte, Mathieu Charvériat, Matthieu Roustit, Dominique Deplanque, Pierre‐Olivier Girodet

septembre 2020 The Journal of allergy and clinical immunology

Type 2-high asthma is associated with a specific indoor mycobiome and microbiome.

Auteurs :

juillet 2020 Clinical & Experimental Allergy

Effectiveness and safety of dupilumab for the treatment of severe asthma in a real‐life French multi‐centre adult cohort

Auteurs :

juin 2020 British journal of clinical pharmacology

Factors associated with serious vehicular accidents: A cross-sectional study in hospital emergency rooms.

Auteurs :

juin 2020 La Revue du praticien

[Therapeutic education, compliance and self-medication].

Auteurs :

avril 2020 Revue des maladies respiratoires

[Management of mild asthma in 2019-2020: What about new international therapeutic proposals (GINA 2019)?]

Auteurs :

février 2020 Therapie

The 2019 Global Initiative for Asthma report: Evidence-based or evidence-biased medicine?

Auteurs :

septembre 2019 The European respiratory journal

Fibrocyte accumulation in the airway walls of COPD patients.

Auteurs :

septembre 2019 International journal of chronic obstructive pulmonary disease

Assessing pulmonary hypertension in COPD. Is there a role for computed tomography?

Auteurs :

juin 2019 Radiology

Automated Volumetric Quantification of Emphysema Severity by Using Ultrashort Echo Time MRI: Validation in Participants with Chronic Obstructive Pulmonary Disease.

Auteurs :

mai 2019 The New England journal of medicine

Benralizumab for the Prevention of COPD Exacerbations.

Auteurs :

février 2019 International journal of chronic obstructive pulmonary disease

Quantitative CT assessment of bronchial and vascular alterations in severe precapillary pulmonary hypertension.

Auteurs :

janvier 2019 Frontiers in immunology

Asthmatic Bronchial Smooth Muscle Increases CCL5-Dependent Monocyte Migration in Response to Rhinovirus-Infected Epithelium.

Auteurs :

décembre 2018 Therapie

Monitoring of drug misuse or potential misuse in a nationwide healthcare insurance database: A cross-sectional study in France.

Auteurs :

octobre 2018

Fibrocyte accumulation in bronchi: a cellular hallmark of COPD

Auteurs : Isabelle Dupin, Matthieu Thumerel, Elise Maurat, Florence Coste, Hugues Begueret, Thomas Trian, Michel Montaudon, Roger Marthan, Pierre-Olivier Girodet, Patrick Berger

octobre 2018 Therapie

Interest of pharmacoepidemiology for the study of inhaled drugs.

Auteurs :

septembre 2018 Lancet (London, England)

Inhaled triple therapy in chronic obstructive pulmonary disease.

Auteurs :

septembre 2017 Biomarker insights

Inhaled Steroids and Active Smoking Drive Chronic Obstructive Pulmonary Disease Symptoms and Biomarkers to a Greater Degree Than Airflow Limitation.

Auteurs :

mai 2017 Respiratory medicine

Efficacy and safety of indacaterol in patients with chronic obstructive pulmonary disease aged over 65 years: A pooled analysis.

Auteurs :

février 2017 The European respiratory journal

Chronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patients.

Auteurs :

janvier 2017 The Journal of allergy and clinical immunology

Identification of airway mucosal type 2 inflammation by using clinical biomarkers in asthmatic patients.

Auteurs :

décembre 2016 The New England journal of medicine

Effectiveness of Fluticasone Furoate-Vilanterol in COPD.

Auteurs :

octobre 2016 American journal of respiratory cell and molecular biology

Alternative Macrophage Activation Is Increased in Asthma.

Auteurs :

avril 2016 Respiratory research

Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study.

Auteurs :

avril 2016 Thorax

CT evaluation of small pulmonary vessels area in patients with COPD with severe pulmonary hypertension.

Auteurs :

avril 2016 Radiology

Quiet Submillimeter MR Imaging of the Lung Is Feasible with a PETRA Sequence at 1.5 T.

Auteurs :

mars 2016 The Journal of allergy and clinical immunology

Reply.

Auteurs :

mars 2016 American journal of respiratory and critical care medicine

Bronchial Smooth Muscle Remodeling in Nonsevere Asthma.

Auteurs :

février 2016 The Journal of allergy and clinical immunology

Vitamin D3 treatment of vitamin D-insufficient asthmatic patients does not alter immune cell function.

Auteurs :

décembre 2015 The Journal of allergy and clinical immunology

Selective dysfunction of p53 for mitochondrial biogenesis induces cellular proliferation in bronchial smooth muscle from asthmatic patients.

Auteurs :

novembre 2015 Respiratory research

Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study.

Auteurs :

octobre 2015 The Journal of allergy and clinical immunology

Blood fibrocytes are recruited during acute exacerbations of chronic obstructive pulmonary disease through a CXCR4-dependent pathway.

Auteurs :

septembre 2015 Fundamental & clinical pharmacology

Choice of ICD-10 codes for the identification of acute coronary syndrome in the French hospitalization database.

Auteurs :

avril 2015 American Journal of Respiratory and Critical Care Medicine

Calcium channel blocker reduces airway remodeling in severe asthma. A proof-of-concept study.

Auteurs :

mars 2015 Radiology

Quiet Submillimeter MR Imaging of the Lung Is Feasible with a PETRA Sequence at 1.5 T.

Auteurs :

mars 2015 American journal of respiratory and critical care medicine

House dust mites induce proliferation of severe asthmatic smooth muscle cells via an epithelium-dependent pathway.

Auteurs :

janvier 2015 American journal of respiratory and critical care medicine

Computed tomographic measurement of airway remodeling and emphysema in advanced chronic obstructive pulmonary disease. Correlation with pulmonary hypertension.

Auteurs :

mars 2014 The Pediatric infectious disease journal

Comparison of Mycoplasma pneumoniae Infections in asthmatic children versus asthmatic adults.

Auteurs :

février 2014 PloS one

Protease activated receptor-2 expression and function in asthmatic bronchial smooth muscle.

Auteurs :

août 2013 Chest

A proof-of-concept, randomized, controlled trial of omalizumab in patients with severe, difficult-to-control, nonatopic asthma.

Auteurs :

février 2013 Journal of clinical pharmacology

Prescription of antiepileptics and the risk of road traffic crash.

Auteurs :

novembre 2012 American journal of respiratory cell and molecular biology

Ca(2+)-activated K(+) channel-3.1 blocker TRAM-34 attenuates airway remodeling and eosinophilia in a murine asthma model.

Auteurs :

octobre 2012 PloS one

In vivo micro-CT assessment of airway remodeling in a flexible OVA-sensitized murine model of asthma.

Auteurs :

septembre 2012 Epidemiology (Cambridge, Mass.)

Prescription-drug-related risk in driving: comparing conventional and lasso shrinkage logistic regressions.

Auteurs :

août 2012 The Journal of clinical psychiatry

Risk of injurious road traffic crash after prescription of antidepressants.

Auteurs :

juillet 2012 Archives of internal medicine

Factors associated with serious traffic crashes: a prospective study in southwest France.

Auteurs :

janvier 2012 American journal of respiratory and critical care medicine

Role of YKL-40 in bronchial smooth muscle remodeling in asthma.

Auteurs :

janvier 2012 Revue des maladies respiratoires

[Asthma exacerbations: pharmacological prevention].

Auteurs :

mars 2011 Clinical pharmacology and therapeutics

Benzodiazepine-like hypnotics and the associated risk of road traffic accidents.

Auteurs :

mars 2011

[Pathophysiology of asthma].

Auteurs : Ozier A, Bara I, Girodet PO, Marthan R, Berger P

février 2011 Pharmacology & therapeutics

Airway remodeling in asthma: new mechanisms and potential for pharmacological intervention.

Auteurs :

février 2011 Respiratory medicine

Control maintenance can be predicted by exhaled NO monitoring in asthmatic patients.

Auteurs :

janvier 2011

The pivotal role of airway smooth muscle in asthma pathophysiology.

Auteurs : Ozier A, Allard B, Bara I, Girodet PO, Trian T, Marthan R, Berger P

novembre 2010 PLoS medicine

Prescription medicines and the risk of road traffic crashes: a French registry-based study.

Auteurs :

février 2010 Allergy

Mast cell adhesion to bronchial smooth muscle in asthma specifically depends on CD51 and CD44 variant 6.

Auteurs :

décembre 2009 Arthritis research & therapy

Phytalgic, a food supplement, vs placebo in patients with osteoarthritis of the knee or hip: a randomised double-blind placebo-controlled clinical trial.

Auteurs :

décembre 2009 European respiratory review : an official journal of the European Respiratory Society

Epidemiology of COPD.

Auteurs :

juin 2009 Fundamental & clinical pharmacology

The chronic oral administration of arginine aspartate decreases secretion of IGF-1 and IGFBP-3 in healthy volunteers.

Auteurs :

avril 2009 European journal of clinical pharmacology

Drug interactions between inhaled corticosteroids and enzymatic inhibitors.

Auteurs :

juillet 2008 Thorax

Multi-professional lung cancer disclosure to change anxiety and depression: an exploratory study.

Auteurs :

février 2008 Revue des maladies respiratoires

[What is the therapeutic response to corticosteroid in smokers with asthma?].

Auteurs :

janvier 2008 Drug safety

Inhaled corticosteroids and adrenal insufficiency: prevalence and clinical presentation.

Auteurs :

décembre 2007 The Journal of experimental medicine

Bronchial smooth muscle remodeling involves calcium-dependent enhanced mitochondrial biogenesis in asthma.

Auteurs :

février 2006 Journal of immunology (Baltimore, Md. : 1950)

Fraktalkine produced by airway smooth muscle cells contributes to mast cell recruitment in asthma.

Auteurs :

décembre 2005 Revue des maladies respiratoires

[IgE and respiratory disease].

Auteurs :

octobre 2005 Allergy

Mast cell myositis: a new feature of allergic asthma?

Auteurs :

septembre 2005 American journal of respiratory cell and molecular biology

RNA interference decreases PAR-2 expression and function in human airway smooth muscle cells.

Auteurs :

avril 2005 Fundamental & clinical pharmacology

Paradoxal effect of salbutamol in an in vitro model of bronchoprotection.

Auteurs :

janvier 2005 Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine

Pharmacological approach to evaluate aerosol pulmonary deposition.

Auteurs :

janvier 2005 Drug safety

Atypical antipsychotics: from potassium channels to torsade de pointes and sudden death.

Auteurs :

décembre 2003 Revue des maladies respiratoires

[Cardiovascular side effects of drugs used in respiratory diseases]

Auteurs :

novembre 2003 Therapie

[Real-life use of inhaler devices for chronic obstructive pulmonary disease in primary care].

Auteurs :

novembre 2003

Tryptase-stimulated human airway smooth muscle cells induce cytokine synthesis and mast cell chemotaxis.

Auteurs : Berger P, Girodet PO, Begueret H, Ousova O, Perng DW, Marthan R, Walls AF, Tunon de Lara JM

avril 2003 Journal of enzyme inhibition and medicinal chemistry

Synthesis and anti-histaminic evaluation of N-phenyl-(alkyl)-5-(dialkylamino)methyl-2-amino-2-oxazolines.

Auteurs :

Membres

Pierre-Olivier GIRODET

Publications 75

Strategies for Identifying Biomarkers in Severe Asthma

Clinical pharmacology: Current innovations and future challenges

Type 2-high asthma is associated with a specific indoor mycobiome and microbiome.

Effectiveness and safety of dupilumab for the treatment of severe asthma in a real‐life French multi‐centre adult cohort

Factors associated with serious vehicular accidents: A cross-sectional study in hospital emergency rooms.

[Therapeutic education, compliance and self-medication].

[Management of mild asthma in 2019-2020: What about new international therapeutic proposals (GINA 2019)?]

The 2019 Global Initiative for Asthma report: Evidence-based or evidence-biased medicine?

Fibrocyte accumulation in the airway walls of COPD patients.

Assessing pulmonary hypertension in COPD. Is there a role for computed tomography?

Automated Volumetric Quantification of Emphysema Severity by Using Ultrashort Echo Time MRI: Validation in Participants with Chronic Obstructive Pulmonary Disease.

Benralizumab for the Prevention of COPD Exacerbations.

Quantitative CT assessment of bronchial and vascular alterations in severe precapillary pulmonary hypertension.

Asthmatic Bronchial Smooth Muscle Increases CCL5-Dependent Monocyte Migration in Response to Rhinovirus-Infected Epithelium.

Monitoring of drug misuse or potential misuse in a nationwide healthcare insurance database: A cross-sectional study in France.

Fibrocyte accumulation in bronchi: a cellular hallmark of COPD

Interest of pharmacoepidemiology for the study of inhaled drugs.

Inhaled triple therapy in chronic obstructive pulmonary disease.

Inhaled Steroids and Active Smoking Drive Chronic Obstructive Pulmonary Disease Symptoms and Biomarkers to a Greater Degree Than Airflow Limitation.

Efficacy and safety of indacaterol in patients with chronic obstructive pulmonary disease aged over 65 years: A pooled analysis.

Chronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patients.

Identification of airway mucosal type 2 inflammation by using clinical biomarkers in asthmatic patients.

Effectiveness of Fluticasone Furoate-Vilanterol in COPD.

Alternative Macrophage Activation Is Increased in Asthma.

Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study.

CT evaluation of small pulmonary vessels area in patients with COPD with severe pulmonary hypertension.

Quiet Submillimeter MR Imaging of the Lung Is Feasible with a PETRA Sequence at 1.5 T.

Reply.

Bronchial Smooth Muscle Remodeling in Nonsevere Asthma.

Vitamin D3 treatment of vitamin D-insufficient asthmatic patients does not alter immune cell function.

Selective dysfunction of p53 for mitochondrial biogenesis induces cellular proliferation in bronchial smooth muscle from asthmatic patients.

Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study.

Blood fibrocytes are recruited during acute exacerbations of chronic obstructive pulmonary disease through a CXCR4-dependent pathway.

Choice of ICD-10 codes for the identification of acute coronary syndrome in the French hospitalization database.

Calcium channel blocker reduces airway remodeling in severe asthma. A proof-of-concept study.

Quiet Submillimeter MR Imaging of the Lung Is Feasible with a PETRA Sequence at 1.5 T.

House dust mites induce proliferation of severe asthmatic smooth muscle cells via an epithelium-dependent pathway.

Computed tomographic measurement of airway remodeling and emphysema in advanced chronic obstructive pulmonary disease. Correlation with pulmonary hypertension.

Comparison of Mycoplasma pneumoniae Infections in asthmatic children versus asthmatic adults.

Protease activated receptor-2 expression and function in asthmatic bronchial smooth muscle.

A proof-of-concept, randomized, controlled trial of omalizumab in patients with severe, difficult-to-control, nonatopic asthma.

Prescription of antiepileptics and the risk of road traffic crash.

Ca(2+)-activated K(+) channel-3.1 blocker TRAM-34 attenuates airway remodeling and eosinophilia in a murine asthma model.

In vivo micro-CT assessment of airway remodeling in a flexible OVA-sensitized murine model of asthma.

Prescription-drug-related risk in driving: comparing conventional and lasso shrinkage logistic regressions.

Risk of injurious road traffic crash after prescription of antidepressants.

Factors associated with serious traffic crashes: a prospective study in southwest France.

Role of YKL-40 in bronchial smooth muscle remodeling in asthma.

[Asthma exacerbations: pharmacological prevention].

Benzodiazepine-like hypnotics and the associated risk of road traffic accidents.

[Pathophysiology of asthma].

Airway remodeling in asthma: new mechanisms and potential for pharmacological intervention.

Control maintenance can be predicted by exhaled NO monitoring in asthmatic patients.

The pivotal role of airway smooth muscle in asthma pathophysiology.

Prescription medicines and the risk of road traffic crashes: a French registry-based study.

Mast cell adhesion to bronchial smooth muscle in asthma specifically depends on CD51 and CD44 variant 6.

Phytalgic, a food supplement, vs placebo in patients with osteoarthritis of the knee or hip: a randomised double-blind placebo-controlled clinical trial.

Epidemiology of COPD.

The chronic oral administration of arginine aspartate decreases secretion of IGF-1 and IGFBP-3 in healthy volunteers.

Drug interactions between inhaled corticosteroids and enzymatic inhibitors.

Multi-professional lung cancer disclosure to change anxiety and depression: an exploratory study.

[What is the therapeutic response to corticosteroid in smokers with asthma?].

Inhaled corticosteroids and adrenal insufficiency: prevalence and clinical presentation.

Bronchial smooth muscle remodeling involves calcium-dependent enhanced mitochondrial biogenesis in asthma.

Fraktalkine produced by airway smooth muscle cells contributes to mast cell recruitment in asthma.

[IgE and respiratory disease].

Mast cell myositis: a new feature of allergic asthma?

RNA interference decreases PAR-2 expression and function in human airway smooth muscle cells.

Paradoxal effect of salbutamol in an in vitro model of bronchoprotection.

Pharmacological approach to evaluate aerosol pulmonary deposition.

Atypical antipsychotics: from potassium channels to torsade de pointes and sudden death.

[Cardiovascular side effects of drugs used in respiratory diseases]

[Real-life use of inhaler devices for chronic obstructive pulmonary disease in primary care].

Tryptase-stimulated human airway smooth muscle cells induce cytokine synthesis and mast cell chemotaxis.

Synthesis and anti-histaminic evaluation of N-phenyl-(alkyl)-5-(dialkylamino)methyl-2-amino-2-oxazolines.

Équipe

Remodelage bronchique